Applications: Used for the quantitative determination of Camidanlumab concentration in serum and plasma.
Sample type: Plasma, Serum
Sensitivity: 35.61 ng/mL
Range: 46.88 - 3,000 ng/mL
Applications: Used for the quantitative determination of Basiliximab concentration in serum and plasma.
Sample type: Plasma, Serum
Sensitivity: 13.31 ng/mL
Range: 23.44 - 1,500 ng/mL
Applications: Used for the quantitative determination of Gevokizumab concentration in serum and plasma.
Sample type: Plasma, Serum
Sensitivity: 27.51 ng/mL
Range: 31.25 - 2,000 ng/mL
Applications: Used for the quantitative determination of Canakinumab concentration in serum and plasma.
Sample type: Plasma, Serum
Sensitivity: 64.37 ng/mL
Range: 62.5 - 4,000 ng/mL
Applications: Used for the quantitative determination of Infliximab concentration in serum and plasma.
Sample type: Plasma, Serum
Sensitivity: 71.38 ng/mL
Range: 93.75 - 3,000 ng/mL
Applications: Used for the quantitative determination of Golimumab concentration in serum and plasma.
Sample type: Plasma, Serum
Sensitivity: 99.16 ng/mL
Range: 125 - 4,000 ng/mL
Applications: Used for the quantitative determination of Certolizumab concentration in serum and plasma.
Sample type: Plasma, Serum
Sensitivity: 329.66 ng/mL
Range: 468.75 - 30,000 ng/mL
Applications: Used for the quantitative determination of Adalimumab concentration in serum and plasma.
Sample type: Plasma, Serum
Sensitivity: 102.26 ng/mL
Range: 62.5 - 4,000 ng/mL
Applications: Used for the quantitative determination of Tanezumab concentration in serum and plasma.
Sample type: Plasma, Serum
Sensitivity: 128.01 ng/mL
Range: 156.25 - 10,000 ng/mL